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Novelty and impact Statements: Chronic high fat diet intake induces metabolic syndrome 
(MeS) and CTBP1 activity in mice. We found that CTBP1 and MeS modulated aromatase 
transcription which elevated estrogen concentrations in prostate tumors. In addition, MeS 
induced inflammation of the white adipose tissue, leading to a proinflammatory 
phenotype and increased serum estradiol concentrations which impacts on prostate 
cancer (PCa) growth. These results have yielded unique insights into the mechanisms that 














Metabolic syndrome (MeS) increases prostate cancer (PCa) risk and aggressiveness. C-
terminal binding protein 1 (CTBP1) is a transcriptional co-repressor of tumor suppressor 
genes that is activated by low NAD+/NADH ratio. Previously, our group established a MeS 
and PCa mice model that identified CTBP1 as a novel link associating both diseases. We 
found that CTBP1 controls the transcription of aromatase (CYP19A1), a key enzyme that 
converts androgens to estrogens. The aim of this work was to investigate the mechanism 
that explains CTBP1 as a link between MeS and PCa based on CYP19A1 and estrogen 
synthesis regulation using PCa cell lines, MeS/PCa mice and adipose co-culture systems. 
We found that CTBP1 and E1A binding protein p300 (EP300) bind to CYP19A1 promoter 
and downregulate its expression in PC3 cells. Estradiol, through the estrogen receptor 
beta, released CTBP1 from CYP19A1 promoter triggering its transcription and modulating 
PCa cell proliferation. We generated NSG and C57BL/6J MeS mice by chronically feeding 
animals with high fat diet. In the NSG model, CTBP1 depleted PCa xenografts showed an 
increase in the CYP19A1 expression with the subsequent increment in intratumor 
estradiol concentrations. Additionally, in C57BL/6J mice, MeS induces hypertrophy, 
hyperplasia and inflammation of the white adipose tissue, which leads to a 
proinflammatory phenotype and increases serum estradiol concentration. Thus, MeS 
increased PCa growth and Ctbp1, Fabp4 and IL-6 expression levels. These results describe, 
for the first time, a novel CTBP1/CYP19A1/Estradiol axis that explains, in part, the 















Prostate cancer (PCa) is still the most prevalent cancer among men and the second leading 
cause of cancer death worldwide1. There is increasing evidence showing that diet and 
lifestyle play a crucial role in PCa risk and progression2–5 Metabolic syndrome (MeS) is a 
cluster of pathophysiological disorders that comprises, at least, three of the following 
factors: visceral adiposity, high triglycerides, low High Density Lipoprotein (HDL) 
cholesterol levels, high blood pressure and high glucose levels6. Recently, a meta-analysis 
revealed that MeS is linked to poor prognosis in PCa patients, increased tumor 
aggressiveness and biochemical recurrence7. 
Previously, our group identified C-terminal binding protein 1 (CTBP1) as a molecular link 
associating PCa and MeS. CTBP1 is a transcriptional co-repressor of tumor suppressor 
genes that is activated with much higher affinity by NADH (>100-fold) compared to NAD+8. 
Hence, we developed a MeS mice model by chronically feeding animals with high fat diet 
(HFD), and found that CTBP1 depletion in MeS mice dramatically decreased PCa and 
breast cancer growth9,10. Moreover, we identified a new molecular mechanism linking PCa 
and MeS based on Chloride Channel Accessory 2 (CLCA2) repression by CTBP1 and miR-
196b-5p molecules that might act as key factors in the progression and onset of this 
disease11. Additionally, we previously reported that CTBP1 depletion in androgen 
insensitive PCa xenografts from HFD-fed mice induced hormone biosynthesis and 
metabolism-related genes, including the aromatase enzyme (CYP19A1) that is involved in 
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CYP19A1 expression deregulation plays an important role in breast and endometrial 
cancer12. It was reported that estrogens induce tumors in several organs13. Although there 
is a growing body of evidence demonstrating that estrogens have effects in the 
progression of prostatic disease, the expression levels of CYP19A1 and the role of 
estrogens in PCa remains controversial14,15. The dual role of estrogen, favorable and 
unfavorable, appears to be mediated trough an opposite action between the estrogen 
receptors ER-α and ER-β. The activation of ER-α leads to aberrant proliferation, 
inflammation and the development of premalignant lesions, while in contrast, the 
activation of ER-β mediates the antiproliferative, anti-inflammatory and, potentially, 
anticarcinogenic effects of estrogen14. Thus, it is important to investigate the synthesis 
and regulation of estrogen production, mediated by aromatase, in the prostate and the 
subsequent effects on prostate disease15. Human CYP19A1 is encoded by a single copy of 
the CYP19A1 gene, localized at chromosome 15q21.216. The human CYP19A1 gene is 
expressed in a tissue- and cell type-specific manner, and the complex expression and 
regulation of CYP19A1 gene is achieved through the use of multiple exons that encode the 
5´UTR region17. 
Visceral adiposity is one of the main aspects of MeS. Adipose tissue (AT) can be classified 
in brown adipose tissue (BAT) and subcutaneous and visceral white adipose tissue (WAT). 
Epidemiological studies correlated visceral adiposity with an increased risk of developing 
certain types of cancer, including colorectal, breast and endometrial18. WAT is an active 
endocrine organ secreting local and systemic hormones (leptin and adiponectin), 
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insulin-like growth factor-binding protein [IGFBPs] and transforming growth factor [TGF-
β])18. In men, WAT is the main site of endogenous estrogen synthesis from androgens by 
the aromatase enzyme located in adipocytes19. Adiposity deposit caused by MeS is 
associated to an increase in aromatase activity and in free circulating estrogen levels, and 
a decrease in free testosterone levels20. Thus, estradiol could be responsible for more 
aggressive prostate tumors20. 
The aim of this work was to investigate the mechanism that explains CTBP1 as a link 
between MeS and PCa based on aromatase and estrogen synthesis regulation. We found 
that CTBP1 and EP300 (E1A binding protein p300) bound directly to CYP19A1 promoter 
and downregulated its expression in PCa cells. In turn, estradiol through ER-β, released 
CTBP1 from CYP19A1 promoter, induced its transcription and modulated PCa cell 
proliferation. Moreover, we developed a NSG (NOD Scid gamma) and C57BL/6J MeS mice 
model by chronically feeding animals with HFD. We observed that CTBP1-depleted PCa 
xenografts in NSG mice showed an increase in the CYP19A1 expression, with the 
consequent increment in intratumor estradiol concentrations. Additionally, MeS induced 
hypertrophy, hyperplasia and inflammation of WAT, which leads to a proinflammatory 
phenotype, serum estradiol concentration increase and PCa growth in C57BL/6J mice. 
Altogether, this study describes for the first time a novel CTBP1/CYP19A1/estradiol axis 
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MATERIALS AND METHODS 
 
Cell culture, transfections and treatments 
PC3 (ATCC: CRL-1435), 22Rv1 (ATCC: CRL-2505), LNCaP (ATCC: CRL-1740), C4-221 cell lines 
and its stable derivatives were grown in RPMI-1640 (Invitrogen) supplemented with 10% 
of fetal bovine serum (FBS) and antibiotics in a 5% CO2 humidified atmosphere at 37°C. 
These cell lines were recently validated at MDA Cancer Center (Texas, USA). PC3.shCTBP1 
and its control (PC3.pGIPZ) stable cell lines were previously described9.  
TRAMP-C1 cell line (ATCC: CRL-2730) was grown in DMEM medium (GIBCO) supplemented 
with 10 % of FBS and antibiotics and 250 UI/µl human recombinant insulin. 
PC3 cells were exposed for 48 or 96 h to estradiol (10 nM, 1 and 10 µM) or ethanol as 
vehicle in phenol red-free RPMI-1640 medium (GIBCO) supplemented with 10% 
charcoaled FBS. 
PC3.pcDNA3 and pcDNA3.CTBP1 cells were generated by transient transfection using 6 μg 
of plasmid and polyethylenimine methodology (PEI - PolySciences INC) with PEI:DNA ratio 
2:1.  
Plasmids 
CTBP1 plasmid and its control (pcDNA3) were previously described10. pGL3 plasmids with 
different lengths of the I.4 and PII CYP19A1 promoter were previously described22,23. ZEB1 
(Zinc finger E-box binding homeobox 1), EP300, E2F1 (E2F transcription factor 1) and RELA 
(RELA proto-oncogene, NF-kB subunit) plasmids were previously reported24–27. STAT3 
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factor-1) plasmids were kindly provided by Dr. James Darnell (Rockefeller University, 
United States), Dr. Christopher K. Glass (University of California, United States), Dr. 
Rodolfo Rey (CEDIE, Argentina) and Dr. Ken-ichirou Morohashi (Kyushu University, Japan), 
respectively.  
Luciferase reporter assay.  
PC3 cells were transfected in 12-well plates in triplicate using PEI and 1 µg of each 
plasmid. After 48 h of transfection, luciferase activity was determined by Luciferase Assay 
system (Promega) according to the manufacturer's instructions using a GloMax® 96 
Microplate Luminometer (Promega). Data were normalized to total protein (determined 
by Bradford assay) and control. 
For estradiol treatment, PC3 cells were transfected with the indicated plasmids and grown 
in RPMI without phenol red supplemented with charcoaled 10% FBS. After 24 h, cells were 
exposed to estradiol (1 and 10 µM) or vehicle for 48 h, and luciferase activity was 
determined as describe above. 
RNA isolation, cDNA synthesis and qPCR (RT-qPCR) 
Total RNA from cells, tumor xenograft, tumor allografts or gWAT was isolated using 
TriReagent (Molecular Research Center). cDNA synthesis was performed using 2 µg of RNA 
and RevertAid First Strand kit (Thermo Scientific). Real time PCR (qPCR) was performed 
using TAQ Pegasus (Productos Bio-Lógicos, Argentina) in a CFX96 Touch™ Real-Time PCR 
Detection System (Bio-Rad). Data was normalized to β-actin (ACTB) and control. Primer 
sequences are shown in Table S1. 
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PC3 cells were exposed to estradiol (1 or 10 µM) or vehicle by 96 h and fixed in 1% 
formaldehyde for 10 min on ice, quenched with 125 mM glycine for 15 min on ice, and 
washed twice in PBS containing PMSF (0.5 mM) and NaF (375 µM). Cell pellets (7.5x106 
cells) were thawed on ice, resuspended in 0.5 mL of lyses buffer [50 mM Tris-HCl (pH 7.4), 
1% SDS] with 1 x protease inhibitor mix (Sigma-Aldrich), and sonicated for 10 min (30 s 
‘‘on’’ and 30 s ‘‘off’’) at high power using a Bioruptor® II Sonicator. This yields DNA 
fragments from 200–500 bp in length, with the bulk of the chromatin at 300 bp. 
Chromatin was immunoprecipitated from 2x106 cells (130 µl of the sonicate) by using 
specific antibodies: 4 µg for CTBP1 (Santa Cruz Biotechnology Inc.), 2 µg for EP30026 or 0.5 
µg for non-specific Gal4 antibody (Santa Cruz Biotechnologies) with recombinant protein 
G beads (Invitrogen) preblocked with BSA (2 mg/mL) and DNAss (2 mg/ml) (Invitrogen). 
The beads were washed with 1 mL of ice-cold high-salt IP buffer [500 mM NaCl, 50 mM 
Tris-HCl (pH 7.4), 5 mM EDTA (pH 8.0), 0.5% Nonidet P-40, and 1% Triton X-100] once and 
three times with 1 mL of low-salt IP buffer [50 mM NaCl, 50 mM Tris-HCl (pH 7.4), 5 mM 
EDTA (pH 8.0), 0.5% Nonidet P-40, and 1% Triton X-100]  (400 g, 2–3 min) and rinsed with 
1ml of TE buffer [10 mM Tris-HCl (pH 8.0), 1 mM EDTA] . Then, 300 µL of buffer TE was 
added to the washed bead pellet, briefly vortexed, and reverse cross-linked with 0.2 
mg/mL Proteinase K (Invitrogen) and 0.5 % SDS at 65 °C 16h. Samples were centrifuged 
(400 g, 3 min, 4°C) and ChIP-DNA in the supernatant was isolated with phenol-chloroform 
isoamyl, resuspended in 100 µl of H2O and amplified by qPCR using specific primers (Table 
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method was used to calculate the fold change expression of each promoter of interest. 
Propagation of error was handled using standard rms methods. 
Western blot (WB) 
Cells were lysed and immunoblotted as previously described28 using specific antibodies: 
anti-CTBP1 (Santa Cruz Biotechnology Inc.), anti-CYP19 (Santa Cruz Biotechnology Inc.) 
and anti-β-Actin (Cell Signaling Technology). Reactions were detected by horseradish 
peroxidase–conjugated secondary antibodies and enhanced chemiluminescence (Pierce) 
following the manufacturer's directions. Protein quantitation was performed using Image J 
1.48 software (http://rsb.info.nih.gov, NIH). 
Cell viability and cell cycle analysis 
PCa cells were grown in media without phenol red (GIBCO) supplemented with charcoal-
stripped 1 or 10% FBS.  After 24 h, cells were exposed to estradiol (10 nM, 1 µM and 10 
µM) or vehicle for 96 h. Cell viability was assayed by MTS (Cell-Titer-96-wells Aqueous 
non-Radioactive Cell-Proliferation Assay, Promega) following the manufacture 
instructions28. For cell cycle analysis, cells were fixed and stained with propidium iodide 
(PI), and analyzed by flow cytometry (FC) as previously described28. 
Immunosuppressed PCa xenograft and MeS murine model 
Four weeks old male NSG (NOD SCID Gamma) mice (N=24), were housed under pathogen 
free conditions following the IBYME’s animal care guidelines. Mice were randomized into 
2 dietary groups and fed ad libitum during 16 weeks with CD (3,120 kcal/kg, 5% fat) or 
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diet, mice were randomly distributed into 2 groups and injected s.c. with PC3.pGIPZ or 
PC3.shCTBP1 cells (4,8X106). Depletion of CTBP1 in PC3 cells was achieved by stably 
transfecting cells with a CTBP1 shRNA (sc-35122 Santa Cruz Biotechnology) vector. CTBP1 
shRNA is a pool of 3 target-specific 19-25 nt siRNAs designed to knock down gene 
expression as previously described9. Tumor volume was determined three times a week 
and calculated as previously described28. Animals were sacrificed in the 16th week and 
tumor, liver, AT and blood samples were collected.  
Non-immunodeficient PCa allografts and MeS murine model 
Four weeks old male C57BL/6J mice (N=12), were housed under pathogen free conditions 
following the IBYME’s animal care guidelines. Mice were randomized into 2 dietary groups 
and fed ad libitum during 27 weeks as described above. After 15 weeks of diet, mice were 
randomly distributed into 2 groups and injected s.c. with TRAMP-C1 (3X106) cell line. 
Tumor volume was determined as described above. Animals were sacrificed in the 27th 
week and tumor, liver, AT and blood samples were collected. Mice serum glucose, 
cholesterol and triglycerides levels were determined as previously described9.  
Histological and immunohistochemical (IHC) analysis  
Tissue samples collected from PCa allografts and MeS mice described above were 
formalin-fixed and paraffin embedded (FFPE). For histological analysis, 4 μm microscopic 
sections were stained with hematoxylin-eosin (H&E) and examined by light microscopy. 
For IHC analysis of CTBP1, anti-CTBP1 antibody (1:400; 621042, BD Transduction 
Laboratories) was used. The procedure was completed using a streptavidin-biotin-complex 
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with 3,3' diaminobenzidine (DAB) as chromogen and examined by light microscopy. IHC 
evaluation was performed by a pathologist without knowledge of the grouping 
information, using the Immunorreactive Score (IRS). The IRS gives a range of 0-12 as a 
product of multiplication between positive cells proportion score (0-4) and staining 
intensity score (0-3). 
Measurement of intratumor and serum estradiol by radioimmunoassay (RIA) 
Serum and intratumor estradiol levels were measured by RIA following ether extraction of 
steroids from 0.25 g of PC3.pGIPZ or PC3.shCTB1 tumors developed in HFD NSG mice or 
C57BL/6J CD or HFD mice, as previously described29. After tissue or serum steroid 
extractions, estradiol levels were determined by RIA using specific antibodies supplied by 
Dr. G.D. Niswender (Colorado State University, Fort Collins, CO) as previously described30. 
Under these conditions, the intra-assay and inter-assay variations were 7.2 % and 12.5% 
respectively. The values are expressed as pg hormone/mg of tissue for tumors and ng/ml 
for serum. 
Ex vivo co-culture of gWAT with TRAMP-C1 cells 
TRAMP-C1 cells were plated in DMEM complete medium into 24-well culture plates at a 
density of 1.5x104 cells/well. After 24 h, medium was refreshed and 150 mg of gWAT 
obtained from CD or HFD C57BL/6J mice were placed onto cell-culture inserts (3.0 micron 
pore size, high-density membrane) in M199 (SIGMA) complete medium. The experiment 
was conducted for a period of 48 h. Then, TRAMP-C1 cells and gWAT were collected in 
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DMEM complete media without the addition of gWAT. Data were normalized to control 
and represent an N=6 from three different mice per group.  
Enzyme-linked immunosorbent assay (ELISA) 
Conditioned media from the co-culture were tested by competitive ELISA assay using BD 
OptEIA™ Set Mouse IL-6 (BD Bioscience, CA, USA) to quantify IL-6 levels following the 
manufacturer recommendations. 
Statistical analysis 
 All results are given as mean and standard deviation (SD) of three independent 
experiments unless stated otherwise. Student t-tests or two-way ANOVA followed by 
Tukey test were performed. Shapiro–Wilk and Levene tests were used to assess normality 
and homogeneity of variances. *, P < 0.05; **, P < 0.01;***, P < 0.001. 
 
Results 
CTBP1 protein binds to CYP19A1 promoter and represses its transcription. 
Based in our previous finding, showing that CTBP1 repressed CYP19A1 in PCa xenografts9, 
in this work we focused on the underlying mechanism of this regulation. First, we 
determined CYP19A1 gene expression in a panel of PCa cell lines, including the androgen 
sensitive LNCaP cells, its derived C4-2 and the androgen insensitive PC3 and 22Rv1 cells. 
We found that PC3 showed the highest CYP19A1 expression (Fig. 1A). Moreover, CTBP1 
overexpression decreased CYP19A1 mRNA and protein levels in PC3 cells (Fig. 1B-C). 
Accordingly, CYP19A1 mRNA was induced after CTBP1 depletion (Fig. 1D). CTBP1 
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Several tissue-specific promoter regions were previously described for CYP19A116. In the 
normal prostate, CYP19A1 is expressed exclusively within the stroma, and is regulated via 
the proximal promoter PII. However, in PCa, CYP19A1 is expressed within the epithelial 
tumor cells, as well as in the stromal cells, and is aberrantly regulated by promoters I.4, PII 
and I.312. To further investigate CYP19A1 promoter activity regulation by CTBP1, I.4 and PII 
reporter constructs, containing different lengths of CYP19A1 promoter regions from the 
TSS, were co-transfected with CTBP1 or control (pcDNA3) plasmids into PC3 cell line. 
CTBP1 significantly repressed the activity of all the different CYP19A1 promoters (Fig. 1E).  
Additionally, we determined that CTBP1 bound specifically to both CYP19A1 promoter 
regions, I.4 and PII by ChIP (Fig. 1F). Hence, CTBP1 associates to CYP19A1 promoter and 
represses its transcription in PC3 cell line. 
 
EP300 binds to CYP19A1 promoters and co-represses its transcription together with 
CTBP1. 
To determine potential transcription factors (TF) that co-regulates with CTBP1 CYP19A1 
transcription, we co-transfected CYP19A1 reporters with a panel of TFs that potentially 
interact with CTBP1 protein. We found that E2F1, STAT3, RELA and SF1 had no effect on 
CYP19A1 promoter activity; however, EP300 repressed while ZEB1 induced its activity in 
PC3 cells (Fig. 2A). Furthermore, CYP19A1 I.4 and PII promoters activity repression by 
CTBP1 was synergistically increased by EP300 (Fig. 2B). More importantly, using ChIP we 
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Although ZEB1 induced CYP19A1 promoter activity, this activation was not influenced by 
CTBP1 co-transfection, suggesting that both factors act independently on CYP19A1 
transcription (Fig. S1A).   
 
Estradiol releases CTBP1 protein from CYP19A1 promoters triggering its transcription 
while EP300 remains attached. 
We investigated CYP19A1 expression regulation by estradiol in PC3 cells. In a panel of PCa 
cell lines, we found that PC3 cells expressed higher levels of ER-α and ER-β compared with 
the other cell lines (Fig. S2). Furthermore, we found that estradiol induced CYP19A1 mRNA 
levels and promoter activity, which was dramatically enhanced by  transfection with ER-β 
plasmid (Fig. 2D-E) while ER-α did not modify CYP19A1 promoter activity (Fig. 2E). 
Moreover, we co-transfected PC3 cells with I.4 or PII luciferase plasmids plus CTBP1, ER-β 
or pcDNA3 vectors and, after 24 h, cells were exposed to estradiol or vehicle during 48 h, 
in order to detect luciferase activity. As shown in Fig. 2F, CTBP1 repressed CYP19A1 
promoter activity, even after estradiol exposure. Notably, CTBP1 attenuated CYP19A1 
promoter activity induction by ER-β and estradiol (Fig. 2F). Additionally, using ChIP we 
determined that CTBP1 and EP300 bound to I.4 and PII CYP19A1 promoters, while 
estradiol exposure released CTBP1 protein from both promoters whilst the co-regulator 
EP300 remain attached (Fig. 2G). 
Altogether, these results elucidate a novel function of estradiol in PCa, showing for the 
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its transcription. Estradiol exposure, through ER-β, releases CTBP1 from CYP19A1 
promoter triggering its expression in androgen-insensitive PCa cells. 
 
Estradiol modulates the viability and cell cycle progression of PCa cell lines. 
Estradiol effects on PCa cell lines have been poorly investigated. Hence, we assessed the 
viability of a panel of PCa cell lines after exposure to estradiol. As shown in Fig. 3A, 
different doses of estradiol significantly increased LNCaP and C4-2 viability; however, it 
decreased PC3 viability, while no changes were found in 22Rv1 cell line. 
In addition, we measured the percentage of LNCaP and PC3 cells in the different cell cycle 
phases after estradiol exposure. We found that estradiol increased 5% the percentage of S 
phase cells and 6% of G2/M cells in LNCaP cells (Fig. 3B). Moreover, estradiol increased 5% 
the G0/G1 phase PC3 cells (Fig. 3B).  
Altogether, these results show that estradiol induces proliferation of androgen-sensitive 
cells, while it diminishes proliferation of androgen-insensitive cell lines suggesting that 
estradiol, ER-β, CTBP1 and EP300 constitute key regulators of CYP19A1 expression and 
activity in PCa.   
 
CTBP1 depletion dramatically increases CYP19A1 expression and estradiol levels in 
xenografts from HFD fed mice. 
Based in our previous results showing that CTBP1 regulated CYP19A1 expression in PC3 
xenografts developed in nude mice fed with HFD9, we further investigated whether this 
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control diet (CD) during 12 weeks were inoculated with control (PC3.pGIPZ) or CTBP1-
depleted (PC3.shCTBP1) PC3 stable cell lines. After 4 to 6 weeks from cell inoculation, 
mice were sacrificed, tumor excised and analyzed. HFD fed mice developed MeS-like 
disease since these animals showed dyslipidemia and liver steatosis at the end of the 
experiment (data not shown), as we previously reported for nude mice model9. Moreover, 
CTBP1 depletion significantly induced CYP19A1 expression only in HFD group (Fig. 3C). 
CTBP1 depletion was confirmed in the animals by RT-qPCR (Fig. 3C). Interestingly, 
xenografts generated from PC3.shCTBP1 cell line showed significantly increased in 
intratumor estradiol levels compared to PC3.pGIPZ xenografts in HFD fed mice (Fig. 3D).  
 
HFD increases TRAMP-C1 allograft tumor growth and serum estradiol levels while 
induces Ctbp1, Fabp4 and IL-6 gene expression. 
Given that MeS increases serum estradiol levels, which impacts on breast tumor 
development31, we investigated the effect of MeS on estrogens levels and PCa 
development. We generated a non-immunodeficient murine model of MeS and PCa using 
C57BL/6J male mice and PCa TRAMP-C1 cells. Even though, aromatase expression was 
undetectable in  TRAMP-C1 cells by RT-qPCR before animal inoculation (data not shown), 
we found that low concentrations of estradiol significantly induced TRAMP-C1 cell 
viability, similarly to the result we found for human LNCaP cells (Fig. 4A). Moreover, we 
injected s.c. TRAMP-C1 cells into C57BL/6J male mice chronically fed with HFD or CD. 
Interestingly, HFD significantly increased tumor growth and serum estradiol in mice (Fig. 
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prolonged HFD intake, since they showed dyslipidemia, hyperglycemia, overweight and 
liver steatosis at the end of the experiment (Fig. S3A-C).  
Surprisingly, molecular analysis of allograft showed that endogen Ctbp1 mRNA levels were 
markedly induced by HFD without changes in Ctbp2 gene expression (Fig. 4D). Moreover, 
CTBP1 IHC and IRS quantitation obtained from these allografts, demonstrated that CTBP1 
protein levels was significantly higher in HFD (IRS = 5) compared to CD (IRS = 3) mice (Fig. 
4E). In addition, HFD increased the expression of other genes: Fabp4 (Fatty Acid Binding 
Protein 4), involved in fatty acid uptake, transport, and metabolism32; and the pro-
inflammatory cytokine IL6 (Interleukin 6) (Fig. 4F). No changes in Er-α or Er-β gene 
expression were observed in the allograft from CD compared to HFD fed mice (Fig. 4F). 
 
HFD increases AT amount, adipocyte size and CLS in mice while induces expression of 
genes involved in adipogenesis and inflammation  
Based on the important role of peri-prostatic AT over prostate tumor cell proliferation and 
migration33, we aimed to elucidate the WAT role in PCa. First, we determined the amount 
of gonadal/epididymal (gWAT) and mesenteric (mWAT) AT from CD and HFD fed C57BL/6J 
mice. We observed a significant accumulation of both ATs in HFD fed mice compared to 
CD (Fig. 5A). A similar result in gWAT was found in HFD NSG mice (Fig. S4A). 
Since gWAT is typically the largest and most accessible fat pad in C57BL/6J mice, we 
continued working with this subtype of AT. Adipocyte hypertrophy was found in gWAT 
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Macrophage infiltration, determined by the presence of Crown-Like Structures (CLS), 
induces chronic mild inflammation, widely considered as a causative factor for insulin 
resistance34. Thus, by H&E staining we found that CLS were prevalent in gWAT from HFD 
fed mice compared with CD fed mice (Fig. 5C). In summary, the increase amount of AT, 
the adipocyte hypertrophy and the high CLS density exhibited in HFD mice, recapitulate 
MeS-like disease in this animal model and allow us to understand CTBP1 as a link between 
PCa and MeS.  
In addition, we isolated RNA from HFD and CD gWAT and analyzed gene expression by RT-
qPCR. We found that Ctbp1, Ctbp2 and Ccnd1 were significantly decreased in gWAT 
obtained from HFD fed mice (Fig. 5D). Although no significant changes were observed in 
Cyp19a1 gene expression in gWAT from HFD fed mice, the dramatic increase in the 
amount and size of the adipocytes might suggest an increase in the concentration of 
estradiol which supports the serum estradiol increase in these mice (Fig. 5). Ctbp1 and 
Ccnd1 gene expression were also reduced, while no changes were observed in Cyp19a1 
expression in gWAT from HFD NSG mice (Fig. S4B). Interestingly, gWAT from HFD fed mice 
showed expression induction of adipogenesis and inflammation markers, including Fabp4, 
Pparg (Peroxisome Proliferator Activated Receptor Gamma), Tnf-α (Tumor Necrosis Factor 
α) and Mcp1 (Monocyte Chemoattractant Protein-1) (Fig. 5E-F and Fig. S4C). 
 
Gonadal/epididymal AT explants from HFD fed mice induced TRAMP-C1 cell 
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To further understand the role of gWAT over prostate tumor cell proliferation and gene 
expression, we co-cultured gWAT from HFD fed mice or CD fed mice with TRAMP-C1 cells. 
Surprisingly, gWAT from HFD fed mice induced TRAMP-C1 proliferation and Ctbp1 and IL6 
gene expression in these cells (Fig. 5G-H), similarly to the allografts developed in HFD 
C57BL/6J mice. Additionally, Ctbp1, Fabp4 and Pparg expression was markedly diminished 
in the co-cultured gWAT from HFD fed mice (Fig. 5I). Moreover, IL-6 protein levels were 
increased in the conditioned medium from TRAMP-C1 cells co-cultured with gWAT from 
HFD mice respect to CD (Fig. 5J). 
 
Discussion 
In this report, we provide evidence of a striking linkage between 
CTBP1/CYP19A1/estradiol and MeS/PCa. Our goal was to understand CTBP1 role and the 
mechanism for PCa risk increase by MeS. Based in our previous studies, showing CTBP1 as 
an important link that associates PCa and MeS9,11, we investigated CYP19A1 regulation by 
CTBP1 using several PCa cell lines and mice models. We found that CTBP1 assembles with 
EP300 to CYP19A1 proximal promoter region and inhibits its transcription in PCa cells. 
Estradiol exposure, through the ER-β, disrupts this binding and displaces CTBP1 protein 
from the CYP19A1 promoter, triggering its transcription. All these data are highly relevant 
since there are few reports showing transcriptional regulation of CYP19A1 expression in 
PCa12,15.    
Another important finding from this work was observed after estradiol treatment of a 
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estradiol decreased the viability and cell cycle progression of PCa androgen insensitive 
cells, while it increased the viability of androgen sensitive cells. 
Using immune-suppressed mice we not only confirmed the previous findings obtained in 
nude mice9, but also we demonstrated that CTBP1 depleted tumors had increased 
concentration of intratumor estradiol, which reinforced the idea of aromatase induction in 
these tumors by HFD and MeS-like disease.  
Other colleagues have shown that PCa cells synthesize estrogens through aromatase15. In 
this work we have shown that there is a complex transcriptional regulation of this enzyme 
mediated by MeS and CTBP1. We demonstrated that estrogens increased proliferation of 
androgen sensitive PCa cells that do not express aromatase (LNCaP and TRAMP-C1). With 
this scenario, new questions arise: if the prostate tumor cell responds to estrogens, but is 
not capable of producing it, where do the estrogens come from? How does MeS increase 
serum estradiol levels? Is AT playing a role in estradiol levels increase? 
To answer these questions, in this work we developed a non-immunodeficient MeS mice 
model (C57BL/6J) whose animals were inoculated with TRAMP-C1 cells. We first 
confirmed that TRAMP-C1 cells used for the in vivo model did not express aromatase and 
responded to estrogens. Moreover, when we injected TRAMP-C1 cells into C57BL/6J male 
mice chronically fed with HFD we found significantly increased tumor growth and serum 
estradiol levels, supporting the idea that MeS increases serum estradiol levels impacting 
PCa development. Also, this model revealed that HFD fed mice showed an increased 
amount of AT, adipocyte hypertrophy, higher CLS density, with also adipogenesis and 
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important feature of MeS. Although no significant changes were observed in Cyp19a1 
gene expression from AT of HFD fed mice, the dramatic increase in the amount and size of 
the adipocytes, and the high density of CLS, might explain the increased concentration of 
serum estradiol in these mice. More important, we described for the first time that 
endogen Ctbp1, Fabp4 and IL6 were transcriptional activated by HFD in tumors. These 
results validated our hypothesis showing CTBP1 as a molecular link that associates MeS 
and PCa growth. Moreover, co-cultures determined that AT from HFD fed mice induced 
proliferation, Ctbp1, Fabp4 and IL6 gene expression in TRAMP-C1 cells and increased IL-6 
production compared to AT from CD fed animals. Furthermore, co-culture experiments 
revealed that AT from HFD fed mice co-cultured with TRAMP-C1 cells showed decreased 
Ctbp1 and Fabp4 expression levels compared to CD AT. FABP4 is a low molecular weight 
protein that transports long-chain fatty acids released from adipocytes and macrophages 
and can exert its metabolic action in a paracrine or exocrine manner. It is also implicated 
in tumorigenesis in different cancer types, including breast, prostate and ovarian cancer, 
and may have an active role in the interaction between tumor and AT32. In fact, FABP4 is 
involved in lipid transfer between adipocytes and ovaric tumor cells, inducing the fatty 
acid oxidation pathway to fuel tumor growth36. In addition, in breast cancer, the 
expression of FABP4 and other adipogenesis-related genes, were downregulated in AT 
adjacent to malignant breast tumors 37. This process is likely due to the active lipolysis and 
atrophy that adipose tissue undergoes when it is in contact with cancer tissue37. This can 
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could be quickly released from AT to extracellular media, to transport fatty acids to 
adjacent tumor cells38.  
Similarly to Wang et al, in the co-culture of PCa cells with gWAT from CD or HFD fed 
mice37, we found that HFD increased the expression of Fabp4 in gWAT, but when AT was 
in contact with prostate tumor cells, there was a drastic decrease in Fabp4 expression, 
compared to gWAT from CD fed mice. Altogether these data suggest that FABP4 could be 
more rapidly released from the adipocytes of HFD fed mice compared to CD for transport 
fatty acids to tumor cells. However, future experiments should be achieved to address this 
concern. 
In summary, these results explain for the first time the molecular mechanism for PCa risk 
increase by MeS (See Fig. 6 for hypothetical model). Thus, estradiol levels increase in 
serum and tumors through MeS/CTBP1/CYP19A1 mechanism, which directly impacts over 
PCa cells proliferation. In this context, AT also contributes to stimulate proliferation. In the 
future, after completely elucidate the important role of AT and CTBP1/CYP19A1/estradiol 
axis for PCa risk, MeS patients might be advised for the elevated PCa risk to modify 
lifestyle habits.   
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FIGURE TO LEGENDS  
Figure 1. CTBP1 represses CYP19A1 transcription in PC3 cell line. A) CYP19A1 mRNA 
levels in PCa cell lines measured by RT-qPCR. B) CYP19A1 and CTBP1 gene expression 
levels by RT-qPCR from CTBP1 overexpressed PC3 cells. C) CYP19A1, CTBP1, and β-Actin 
protein levels from CTBP1 overexpressed PC3 cells by WB. Quantification and 
normalization to β-Actin protein levels and pcDNA3 are shown under each band. One 
representative experiment from two biologic replicates is shown. D) CYP19A1 and CTBP1 
gene expression levels by RT-qPCR from PC3.pGIPZ and PC3.shCTBP1 stable cell lines. Bars 
indicate mean and SD of two independent experiments. E) Plasmids with different length 
of the I.4 (PG1 to PG10) or PII CYP19A1 promoters were co-transfected with CTBP1 or 
control (pcDNA3) plasmids in PC3 cells, and Luciferase activity was determined. Bars 
indicate mean and SD of two independent experiments with three replicates. F) ChIP-qPCR 
using CTBP1 or nonspecific (Gal4) antibodies and primers located at -0.5 Kb and 0 Kb 
upstream of the TSS of CYP19A1 or -0.2 Kb upstream of the HBB TSS promoter region. Fold 
enrichment was calculated normalizing data to input and Gal4. Bars represent the average 
and SD from one representative experiment. 
 
Figure 2. EP300 , CTBP1, ER-β and estradiol regulates CYP19A1 transcription. A) PC3 cells 
were co-transfected with the I.4 CYP19A1 promoter reporter (-1004/+14) (PG1-luc) and 
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Luciferase activity was determined. Mean of two independent experiments with three 
replicates and SD is plotted. B) PC3 cells were co-transfected with PG1-luc or PII (-
516/+16) (PII-luc) CYP19A1 promoter reporters and CTBP1 or control (pcDNA3) plasmids 
plus EP300 and Luciferase activity was determined. Mean of two independent 
experiments with three replicates and SD is plotted. C) ChIP-qPCR using EP300 or 
nonspecific (Gal4) antibodies and primers located at -0.5 Kb and 0 Kb upstream of the TSS 
of CYP19A1 or -0.2 Kb upstream of the HBB TSS promoter region. Fold enrichment was 
calculated normalizing data to input and Gal4. Bars represent the average and SD from 
one representative experiment. D) mRNA CYP19A1 levels measured by RT-qPCR from PC3 
cells after ER-β plasmid transfection and exposed to estradiol (E2) for 96 h. Mean of two 
independent experiments and SD is plotted. E) PC3 cells were co-transfected with PG1-luc 
promoter reporter and pcDNA3, ER-α or ER-β expression plasmids. After 24 h, cells were 
exposed to estradiol or vehicle for 48 h and Luciferase activity was determined. Mean of 
two independent experiments with three replicates and SD is plotted. F) PC3 cells were 
co-transfected with PG1-luc or PII-luc promoter reporters and CTBP1 or control (pcDNA3) 
plasmids plus ER-β. After 24 h, cells were exposed to estradiol or vehicle for 48 h and 
Luciferase activity was determined. Mean of two independent experiments with three 
replicates and SD is plotted. a) CTBP1 E2 0 vs CTBP1+ER-β E2 1 μM. b) CTBP1 E2 0 vs 
CTBP1+ER-β E2 10 μM. c) pcDNA3 E2 0 vs CTBP1+ER-β E2 10 μM. G) PC3 cells were grown in 
RPMI without phenol red supplemented with charcoal-stripped 10% FBS. After 24 h, cells 
were exposed to estradiol or vehicle for 96 h. ChIP-qPCR using CTBP1, EP300 or 
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of CYP19A1 or -0.2 Kb upstream of the HBB TSS promoter region. Fold enrichment was 
calculated normalizing data to input and Gal4. Bars represent the average and SD from 
one representative experiment. 
 
Figure 3. Estradiol modulates the viability and cell cycle progression of a panel of PCa 
cell lines. A) PCa cells were grown in RPMI without phenol red supplemented with 
charcoal-stripped 10% FBS. After 24 h, cells were exposed to estradiol or vehicle for 96 h 
and cell viability was determined by MTS assay. Mean of three replicates and SD is 
plotted. Data were normalized to E2 0. B) PCa cells were grown in RPMI media without 
phenol red supplemented with charcoal-stripped 10% or 1 % FBS. After 24 h, cells were 
exposed to estradiol or vehicle for 96 h and cell cycle analysis was performed. The figure 
shows the percentage of cells in G0/G1, S, and G2/M phases from two biological 
replicates. C) CYP19A1 and CTBP1 RT-qPCR from xenografts with CTBP1 depleted 
(PC3.shCTBP1) or control (PC3.pGIPZ) expression generated in HFD or CD fed NSG mice. D) 
Intratumor estradiol levels from xenografts with CTBP1 depleted (PC3.shCTBP1) or control 
(PC3.pGIPZ) expression generated in HFD fed NSG mice were measured by RIA. Boxes 
represent the interquartile range, the horizontal line within each box represents the 
median, and the upper and lower whiskers represent the SD of one experiment (N=6). 
 
Figure 4. HFD increases TRAMP-C1 allograft tumor growth and serum estradiol levels 
while induces Ctbp1, Fabp4 and IL-6 gene expression. A) TRAMP-C1 cells were grown in 
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were exposed to estradiol or vehicle for 96 h and cell viability was determined by MTS 
assay. Mean of three replicates and SD is plotted. Data were normalized to E2 0. B) Tumor 
growth from CD or HFD C57BL/6J mice inoculated with TRAMP-C1 cell line. Curves indicate 
media and SD values of one representative experiment (n=6). C) Serum estradiol levels 
from CD or HFD fed C57BL/6J mice were measured by RIA. Boxes represent the 
interquartile range, the horizontal line within each box represents the median, and the 
upper and lower whiskers represent the standard deviation of one independent 
experiment (n=6). D) Ctbp1 and Ctbp2 RT-qPCR from HFD or CD allografts samples. Data 
were normalized to ACTB and control. E) CTBP1 IHC from tumor allografts  developed in 
CD or HFD fed C57BL/6J mice. Magnification 100x and 400x. F) RT-qPCR from HFD or CD 
allografts samples using specific primers for the indicated genes. Data were normalized to 
ACTB and control. 
 
Figure 5. MeS induces alterations of gWAT which induces TRAMP-C1 cell proliferation 
and Ctbp1/IL6 gene expression. 
A) Mesenteric and gonadal/epididymal fat depots weights from CD or HFD fed C57BL/6J 
mice. B) H&E of gWAT from CD or HFD fed C57BL/6J mice. Arrows indicate representative 
adipocytes. Box plot represent adipocyte size quantitation calculated by Image J. C) H&E 
of gWAT from CD of HFD fed C57BL/6J mice showing in high magnification CLS. 
Magnification 100 and 400x. Bars represent media and SD of the CLS counts per mm2. D-F) 
RT-qPCR from gWAT samples obtained from CD or HFD fed C57BL/6J mice using specific 
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cancer cells were counted after co-cultured with gWAT obtained from CD of HFD C57BL/6J 
fed mice for 48 h. As control, TRAMP-C1 cells were incubated in DMEM complete media 
without the addition of gWAT. Data were normalized to control and represent mean and 
SD of three independent experiments with six replicates. H) RT-qPCR from TRAMP-C1 cells 
obtained from the co-culture using specific primers for the indicated genes. Data were 
normalized to ACTB and control and represent mean and SD of two independent 
experiments with three replicates. I) RT-qPCR from gWAT obtained from the co-culture 
using specific primers for the indicated genes. Data were normalized to ACTB and control 
and represent the mean and SD of two independent experiments with three replicates. J) 
IL-6 production was measured in supernatant from the co-cultures. Bars represent 
average and SD of three independent experiments with three replicates. 
 
Figure 6. Hypothetical model: 1) CTBP1 protein assembles with EP300 to I.4 and PII 
CYP19A1 proximal promoter regions and represses its transcription in Androgen 
insensitive (AI) PCa cells. 2) MeS induces adipogenesis, which increases amount of AT, and 
AT inflammation resulting in IL-6 and serum estradiol concentration induction. 3) Estradiol 
from this conversion, through ER-β, releases CTBP1 from CYP19A1 promoters, induces its 
transcription and decreases AI PCa cell proliferation. 4) Estradiol increases Androgen 
sensitive (AS) PCa cell proliferation. In addition, MeS transcriptionally activates endogen 
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